Cargando…
Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis
Generalized bullous fixed drug eruption (GBFDE) is the most severe form of fixed drug eruption and can be misdiagnosed as epidermal necrolysis (EN). We report the case of a 42-year-old male patient presenting with more than 50% skin detachment without defined areas of exanthema or erythema and a his...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461315/ https://www.ncbi.nlm.nih.gov/pubmed/37644986 http://dx.doi.org/10.3389/fmed.2023.1125754 |
_version_ | 1785097824270024704 |
---|---|
author | Paulmann, Maren Reinkemeier, Felix Lehnhardt, Marcus Mockenhaupt, Maja |
author_facet | Paulmann, Maren Reinkemeier, Felix Lehnhardt, Marcus Mockenhaupt, Maja |
author_sort | Paulmann, Maren |
collection | PubMed |
description | Generalized bullous fixed drug eruption (GBFDE) is the most severe form of fixed drug eruption and can be misdiagnosed as epidermal necrolysis (EN). We report the case of a 42-year-old male patient presenting with more than 50% skin detachment without defined areas of exanthema or erythema and a history of one prior event of EN caused by acetaminophen (paracetamol), allopurinol, or amoxicillin 1.5 years ago. The initial diagnosis was GBFDE or EN. The histology of a skin biopsy was unable to distinguish between the two diseases. The course of the disease, the later clinical presentation, and the medical and medication history, however, were in favor of a diagnosis of GBFDE with two potentially culprit drugs: metamizole and ibuprofen. Moxifloxacin, enoxaparin sodium, hydromorphone, and insulin human were administered concomitantly, which makes them suspicious as well. Unfortunately, the patient received an additional dose of metamizole, one of the possible causative drugs, and he developed another bullous reaction within 1 month. This led to the diagnosis of GBFDE due to metamizole. This report highlights the challenges of distinguishing two rare diseases and elucidates the importance of distinct clinical presentation and detailed medication history. |
format | Online Article Text |
id | pubmed-10461315 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104613152023-08-29 Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis Paulmann, Maren Reinkemeier, Felix Lehnhardt, Marcus Mockenhaupt, Maja Front Med (Lausanne) Medicine Generalized bullous fixed drug eruption (GBFDE) is the most severe form of fixed drug eruption and can be misdiagnosed as epidermal necrolysis (EN). We report the case of a 42-year-old male patient presenting with more than 50% skin detachment without defined areas of exanthema or erythema and a history of one prior event of EN caused by acetaminophen (paracetamol), allopurinol, or amoxicillin 1.5 years ago. The initial diagnosis was GBFDE or EN. The histology of a skin biopsy was unable to distinguish between the two diseases. The course of the disease, the later clinical presentation, and the medical and medication history, however, were in favor of a diagnosis of GBFDE with two potentially culprit drugs: metamizole and ibuprofen. Moxifloxacin, enoxaparin sodium, hydromorphone, and insulin human were administered concomitantly, which makes them suspicious as well. Unfortunately, the patient received an additional dose of metamizole, one of the possible causative drugs, and he developed another bullous reaction within 1 month. This led to the diagnosis of GBFDE due to metamizole. This report highlights the challenges of distinguishing two rare diseases and elucidates the importance of distinct clinical presentation and detailed medication history. Frontiers Media S.A. 2023-08-14 /pmc/articles/PMC10461315/ /pubmed/37644986 http://dx.doi.org/10.3389/fmed.2023.1125754 Text en Copyright © 2023 Paulmann, Reinkemeier, Lehnhardt and Mockenhaupt. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Paulmann, Maren Reinkemeier, Felix Lehnhardt, Marcus Mockenhaupt, Maja Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis |
title | Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis |
title_full | Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis |
title_fullStr | Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis |
title_full_unstemmed | Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis |
title_short | Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis |
title_sort | case report: generalized bullous fixed drug eruption mimicking epidermal necrolysis |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461315/ https://www.ncbi.nlm.nih.gov/pubmed/37644986 http://dx.doi.org/10.3389/fmed.2023.1125754 |
work_keys_str_mv | AT paulmannmaren casereportgeneralizedbullousfixeddrugeruptionmimickingepidermalnecrolysis AT reinkemeierfelix casereportgeneralizedbullousfixeddrugeruptionmimickingepidermalnecrolysis AT lehnhardtmarcus casereportgeneralizedbullousfixeddrugeruptionmimickingepidermalnecrolysis AT mockenhauptmaja casereportgeneralizedbullousfixeddrugeruptionmimickingepidermalnecrolysis |